The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries

The final text of the Trans Pacific Partnership Agreement (TPP), agreed between the 12 negotiating countries in 2016, included a suite of intellectual property provisions intended to expand and extend pharmaceutical company exclusivities on medicines. It drew wide criticism for including such provis...

Descripción completa

Detalles Bibliográficos
Autores principales: Gleeson, Deborah, Lexchin, Joel, Lopert, Ruth, Kilic, Burcu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892849/
https://www.ncbi.nlm.nih.gov/pubmed/29706802
http://dx.doi.org/10.1177/1468018117734153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892849/
https://www.ncbi.nlm.nih.gov/pubmed/29706802
http://dx.doi.org/10.1177/1468018117734153

Ejemplares similares